Company Search:
Advanced Search
Sponsored Links
Pharnext SA Company Snapshot
Pharnext SA operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Pharnext SA with three other pharmaceutical manufacturers in Europe: Oncimmune Holdings PLC of UNITED KINGDOM (2019 sales of £171,000.00 [US$221,503.14 ] of which 100% was Distribution of testing products), Kancera AB of SWEDEN (3.22 million Swedish Kronor [US$366,463.20 ] of which 100% was Operations), and Oasmia Pharmaceutical AB which is also based in SWEDEN (1.98 million Swedish Kronor [US$225,621.00 ] of which 65% was Sales of goods).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Pharnext SA
  Stock Performance Chart for Pharnext SA
  Stock Data: Recent Stock Performance:
  Current Price (9/18/2020): 3.33
(Figures in Euros )
1 Week -1.5%   13 Weeks 0.0%  
4 Weeks -6.5%   52 Weeks -43.4%  
Pharnext SA Key Data:
  Ticker: ALPHA Country: France
  Exchanges: PAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 252,773
(Year Ending Jan 2020).
Employees: 44
  Currency: Euros Market Cap: 50,783,283
  Fiscal Yr Ends: December Shares Outstanding: 15,250,235
  Share Type: Actions Ordinaires Closely Held Shares: 11,366,430
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.